Researchers expanded the ability of the genetic editing technique known as Crispr to alter the make-up of RNA, adding more ways to treat diseases. . . . → Read More: Crispr Enhanced for RNA Editing
|
|||||
|
|
An analysis of gut microbes from elite athletes identified a particular bacterial strain, which in tests with lab mice boosted their exercise endurance. . . . → Read More: Gut Microbe Linked to Longer Exercise Endurance  Comments are closed  New products  biomedical, biotechnology, engineering, entrepreneurs, genomics, licensing, life sciences, pharmaceuticals, preclinical, university 
Tests of synthetic cannabidiol, or CBD, show the compound is as effective as current antibiotics against a class of microbes that includes Staphyloccocus and Streptococcus bacteria. . . . → Read More: CBD Shown Effective Against Staph, Strep Bacteria Comments are closed Joint ventures/collaborations, New products Australia, biomedical, biotechnology, life sciences, pharmaceuticals, preclinical, university 
A configurable chip device simulating several human organs is shown in lab tests to simultaneously test cancer drugs for both their efficacy and toxicity. . . . → Read More: Chip Device Tests for Cancer Drug Efficacy, Toxicity Comments are closed New products biomedical, cancer, engineering, entrepreneurs, grant, heart disease, life sciences, medical device, NIH, pharmaceuticals, preclinical, university 
Researchers in Finland are designing techniques using temperature-controlled lasers to treat a common form of vision loss associated with aging. . . . → Read More: Laser Treatments Developed for Age-Related Vision Loss Comments are closed Finance, New products biomedical, engineering, Europe, grant, life sciences, mathematics, medical device, physical sciences, preclinical, university 
A university spin-off company is receiving a foundation grant to advance its Crispr technology targeting RNA to treat a form of muscular dystrophy. . . . → Read More: Foundation Supports Muscular Dystrophy RNA Therapy Comments are closed Finance, New products biomedical, biotechnology, entrepreneurs, grant, investment, licensing, life sciences, pharmaceuticals, preclinical, university, venture capital 
Biochemistry labs in the U.S. and Mexico isolated and synthesized key compounds from scorpion venom that kills bacteria resistant to antibiotics. . . . → Read More: Antibiotics Synthesized from Scorpion Venom One comment - (Comments are closed) New products biomedical, biotechnology, chemistry, life sciences, pharmaceuticals, physical sciences, preclinical, university 
Researchers successfully identified a common drug compound, a non-steroidal anti-inflammatory, that is active against all growing stages of the parasite that causes schistosomiasis. . . . → Read More: Repurposing an Anti-Inflammatory Drug to Treat a Life-Threatening Disease Comments are closed Regulations biomedical, contributed, health care, life sciences, pharmaceuticals, preclinical, university 
Lab mice with bacteria transplanted from human intestines show signs that autism behaviors may result from the state of their gut microbes. . . . → Read More: Gut Microbe Links to Autism Revealed Comments are closed New products biomedical, biotechnology, entrepreneurs, life sciences, pharmaceuticals, preclinical, university 
A synthetic form of cannabidiol, or CBD, a derivative of cannabis, is shown in tests with lab rats to reduce the occurrence of seizures from epilepsy. . . . → Read More: Synthetic Cannabidiol Shown to Reduce Seizures One comment - (Comments are closed) New products biomedical, chemistry, entrepreneurs, FDA, life sciences, patent, pharmaceuticals, physical sciences, preclinical, U.K., university |
||||
|
Copyright © 2019 Technology News and Literature - All Rights Reserved Powered by WordPress & Atahualpa |
|||||